Leidos to support Naval Health Research Center with studies to improve health and readiness of U.S. service members
RESTON, Va., Aug. 25, 2026 /PRNewswire/ -- Leidos (NYSE:LDOS) was recently awarded a contract by the Naval Health Research Center (NHRC) to provide behavioral health research, operational assessments, and data-driven analyses that strengthen the psychological health and operational...
Covered in this story
What has happened since
- Leidos is down 5.1% since this was published, 56 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Leidos
- JPMorgan: $115 → $142 by Oct 2027 · Neutral via Investing.com
- TD Cowen: $129 → $135 by Sep 2027 · Hold via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $LDOS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Leidos →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.